New Treatments for Metastatic Breast Cancer
Hormone receptor-positive/HER2-negative HER2-positive Triple-negative CDK inhibitors Palbociclib with bazedoxifene in HR-positive breast cancer NCT02448771 CDK4/CDK6 inhibitor, ribociclib (LEE011), in combination with trastuzumab or T-DM1 for HER2-positive advanced/MBC NCT02657343 Palbociclib…